OKYO Pharma (OKYO) Competitors $2.65 +0.01 (+0.38%) Closing price 04:00 PM EasternExtended Trading$2.64 -0.01 (-0.23%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OKYO vs. SIGA, UPXI, SVRA, ATYR, PRTC, FLGC, SNDL, CMPS, KOD, and ERASShould you be buying OKYO Pharma stock or one of its competitors? The main competitors of OKYO Pharma include Siga Technologies (SIGA), Upexi (UPXI), Savara (SVRA), aTyr Pharma (ATYR), PureTech Health (PRTC), Flora Growth (FLGC), SNDL (SNDL), COMPASS Pathways (CMPS), Kodiak Sciences (KOD), and Erasca (ERAS). These companies are all part of the "pharmaceutical products" industry. OKYO Pharma vs. Its Competitors Siga Technologies Upexi Savara aTyr Pharma PureTech Health Flora Growth SNDL COMPASS Pathways Kodiak Sciences Erasca Siga Technologies (NASDAQ:SIGA) and OKYO Pharma (NASDAQ:OKYO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Which has more volatility & risk, SIGA or OKYO? Siga Technologies has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, OKYO Pharma has a beta of -0.09, meaning that its stock price is 109% less volatile than the S&P 500. Does the media favor SIGA or OKYO? In the previous week, Siga Technologies had 1 more articles in the media than OKYO Pharma. MarketBeat recorded 4 mentions for Siga Technologies and 3 mentions for OKYO Pharma. OKYO Pharma's average media sentiment score of 0.63 beat Siga Technologies' score of 0.62 indicating that OKYO Pharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Siga Technologies 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OKYO Pharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate SIGA or OKYO? OKYO Pharma has a consensus price target of $7.00, suggesting a potential upside of 164.15%. Given OKYO Pharma's stronger consensus rating and higher possible upside, analysts clearly believe OKYO Pharma is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, SIGA or OKYO? Siga Technologies has higher revenue and earnings than OKYO Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiga Technologies$138.72M4.39$59.21M$1.137.52OKYO PharmaN/AN/A-$4.71MN/AN/A Is SIGA or OKYO more profitable? Siga Technologies has a net margin of 45.73% compared to OKYO Pharma's net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat OKYO Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Siga Technologies45.73% 40.52% 35.62% OKYO Pharma N/A N/A N/A Do insiders and institutionals have more ownership in SIGA or OKYO? 55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 3.0% of OKYO Pharma shares are held by institutional investors. 2.0% of Siga Technologies shares are held by insiders. Comparatively, 40.5% of OKYO Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummarySiga Technologies beats OKYO Pharma on 8 of the 13 factors compared between the two stocks. Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OKYO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OKYO vs. The Competition Export to ExcelMetricOKYO PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.67M$3.13B$5.68B$9.80BDividend YieldN/A2.23%4.59%4.07%P/E RatioN/A20.7930.6825.54Price / SalesN/A371.51463.80116.04Price / CashN/A43.0338.2159.48Price / Book-16.568.638.996.13Net Income-$4.71M-$54.65M$3.25B$264.89M7 Day Performance-18.96%6.59%4.76%2.66%1 Month Performance-3.64%9.57%6.72%3.05%1 Year Performance170.38%14.06%30.51%25.05% OKYO Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OKYOOKYO Pharma3.1547 of 5 stars$2.65+0.4%$7.00+164.2%+164.0%$99.67MN/A0.007Gap UpHigh Trading VolumeSIGASiga Technologies1.9166 of 5 stars$6.58-1.0%N/A-28.3%$470.36M$138.72M9.8340UPXIUpexi3.0176 of 5 stars$5.26+4.8%$15.50+194.7%+94.2%$470.04M$16.56M0.00130News CoverageAnalyst UpgradeShort Interest ↑SVRASavara2.9914 of 5 stars$2.70+4.9%$5.60+107.6%-29.3%$466.15MN/A-5.6220News CoverageEarnings ReportAnalyst UpgradeGap UpATYRaTyr Pharma2.3882 of 5 stars$5.22+3.9%$20.20+287.3%+169.7%$464.14M$230K-6.4453Short Interest ↑PRTCPureTech Health2.7806 of 5 stars$18.58-2.7%$45.00+142.2%-24.7%$446.41M$4.32M0.00100News CoverageShort Interest ↓Gap UpFLGCFlora Growth3.327 of 5 stars$19.68-8.4%$156.00+692.9%-33.8%$444.07M$59.51M-22.36280Positive NewsShort Interest ↓High Trading VolumeSNDLSNDL2.2232 of 5 stars$1.67+1.5%$4.00+140.2%-2.3%$437.53M$671.81M-6.172,516Positive NewsOptions VolumeGap UpCMPSCOMPASS Pathways2.6646 of 5 stars$4.49-2.5%$16.29+263.0%-38.3%$430.48MN/A-2.44120KODKodiak Sciences2.5728 of 5 stars$8.12+11.0%$9.00+10.9%+293.7%$428.15MN/A-2.2490News CoverageEarnings ReportAnalyst UpgradeERASErasca2.4332 of 5 stars$1.51+7.5%$4.57+203.7%-39.4%$426.35MN/A-2.43120News CoverageEarnings Report Related Companies and Tools Related Companies SIGA Alternatives UPXI Alternatives SVRA Alternatives ATYR Alternatives PRTC Alternatives FLGC Alternatives SNDL Alternatives CMPS Alternatives KOD Alternatives ERAS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OKYO) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access